Institute of Human Virology at the University of Maryland School of Medicine — Washington D.C., District of Columbia

Institute of Human Virology at the University of Maryland School of Medicine is a clinical research site located in Washington D.C., District of Columbia, United States 20002.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Institute of Human Virology at the University of Maryland School of Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cocaine Use Disorder, HIV.

Sponsors: University of Maryland, Baltimore.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute of Human Virology at the University of Maryland School of Medicine?

Institute of Human Virology at the University of Maryland School of Medicine has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute of Human Virology at the University of Maryland School of Medicine conducted?

Institute of Human Virology at the University of Maryland School of Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Cocaine Use Disorder, HIV.

Is Institute of Human Virology at the University of Maryland School of Medicine accredited by Crixeo Health?

Institute of Human Virology at the University of Maryland School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute of Human Virology at the University of Maryland School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.